mTh1 driven expression of hTDP-43 results in typical ALS/FTLD neuropathological symptoms.

mTh1 driven expression of hTDP-43 results in typical ALS/FTLD neuropathological symptoms.

Transgenic mouse models are indispensable tools to mimic human diseases and analyze the effectiveness of related new drugs. For a long time amyotrophic lateral sclerosis (ALS) research depended on only a few mouse models that exhibit a very strong and early phenotype, e.g. SOD1 mice, resulting in a...

Full description

Bibliographic Details
Main Authors:	Barbara Scherz, Roland Rabl, Stefanie Flunkert, Siegfried Rohler, Joerg Neddens, Nicole Taub, Magdalena Temmel, Ute Panzenboeck, Vera Niederkofler, Robert Zimmermann, Birgit Hutter-Paier
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5963763?pdf=render

Similar Items

Evaluation of Neuropathological Features in the SOD1-G93A Low Copy Number Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
by: Agnes Molnar-Kasza, et al.
Published: (2021-06-01)

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
by: Sarah Pickles, et al.
Published: (2022-07-01)

Phosphorylation of different tau sites during progression of Alzheimer’s disease
by: Joerg Neddens, et al.
Published: (2018-06-01)

Towards a TDP-43-based biomarker for ALS and FTLD
by: Feneberg, E, et al.
Published: (2018)

The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
by: Britt A. Berning, et al.
Published: (2019-04-01)

Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors
by: Luigi Fiondella, et al.
Published: (2023-04-01)

Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD
by: Yoshitaka Tamaki, et al.
Published: (2022-10-01)

Non-invasive characterization of amyotrophic lateral sclerosis in a hTDP-43A315T mouse model: A PET-MR study
by: Akila Weerasekera, et al.
Published: (2020-01-01)

C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation
by: Keith A. Josephs, et al.
Published: (2019-07-01)

Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD
by: Alistair Wood, et al.
Published: (2021-04-01)

Codon-optimized TDP-43 mediates neurodegeneration in a Drosophila model of ALS/FTLD
by: Tanzeen Yusuff, et al.
Published: (2023-03-01)

NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility
by: Amanda M. Gleixner, et al.
Published: (2022-06-01)

Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)
by: Guinevere F. Lourenco, et al.
Published: (2015-10-01)

Constant Levels of Tau Phosphorylation in the Brain of htau Mice
by: Joerg Neddens, et al.
Published: (2020-08-01)

Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
by: Shunsuke Koga, et al.
Published: (2023-07-01)

Regional and hemispheric susceptibility of the temporal lobe to FTLD-TDP type C pathology
by: V. Borghesani, et al.
Published: (2020-01-01)

Publisher Correction to: Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
by: Shunsuke Koga, et al.
Published: (2023-07-01)

Decreased plasma Aβ in hyperlipidemic APPSL transgenic mice is associated with BBB dysfunction
by: Tina eLöffler, et al.
Published: (2016-06-01)

FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion.
by: Bäumer, D, et al.
Published: (2014)

Correlation of pyroglutamate amyloid β and ptau Ser202/Thr205 levels in Alzheimer's disease and related murine models.
by: Joerg Neddens, et al.
Published: (2020-01-01)

Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium.
by: Kovacs, G, et al.
Published: (2013)

The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons
by: Daiyu Honda, et al.
Published: (2014-01-01)

Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model
by: Amschl David, et al.
Published: (2013-01-01)

FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases
by: Holmerová Iva, et al.
Published: (2011-05-01)

Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one family
by: Anne Sieben, et al.
Published: (2018-01-01)

Quantification of Huntington’s Disease Related Markers in the R6/2 Mouse Model
by: Estibaliz Etxeberria-Rekalde, et al.
Published: (2021-01-01)

Human Endogenous Retrovirus-K and TDP-43 Expression Bridges ALS and HIV Neuropathology
by: Renée N. Douville, et al.
Published: (2017-10-01)

Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology
by: Kyota Fujita, et al.
Published: (2018-01-01)

Editorial: The role of gene mutations in the neuropathology of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD)– Progress and challenges
by: Claire Troakes, et al.
Published: (2023-02-01)

Median polish for final grades of MTH3000- and MTH4000- level courses
by: Fitrianto, Anwar, et al.
Published: (2014)

Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD
by: Tariq Afroz, et al.
Published: (2023-04-01)

Neurofilament-Light Chain as Biomarker of Neurodegenerative and Rare Diseases With High Translational Value
by: Tina Loeffler, et al.
Published: (2020-06-01)

Aberrant TDP‐43 phosphorylation: a key wind gap from TDP‐43 to TDP‐43 proteinopathy
by: Zi‐Qi Huang, et al.
Published: (2021-06-01)

Corrigendum to “The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons” [FEBS Open Bio 4 (2014) 1–10]
by: Daiyu Honda, et al.
Published: (2014-01-01)

DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation
by: Manami Deshimaru, et al.
Published: (2021-04-01)

TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy
by: Lumi Zhang, et al.
Published: (2020-01-01)

Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
by: Rachel Keszycki, et al.
Published: (2023-06-01)

Importance of Functional Loss of FUS in FTLD/ALS
by: Shinsuke Ishigaki, et al.
Published: (2018-05-01)

Editorial: Neuronopathic lysosomal storage diseases - specific neuronal characteristics and therapeutic approaches
by: Stefanie Flunkert, et al.
Published: (2022-11-01)

Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer’s Disease
by: Janine Kutzsche, et al.
Published: (2017-10-01)